Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next ...
This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...
Panther is inviting pharmaceutical and biotechnology partners to co-develop higher-efficacy, lower-toxicity, shelf-stable therapies using its MAP platform. We believe rethinking how treatments are ...
CR-001 IND cleared by U.S. FDA; Phase 1/2 ASCEND global clinical trial to evaluate CR-001 in first-line and previously treated patients on track to initiate in first quarter of 2026, with ...
Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has received IND clearance from the US Food and Drug Administration (FDA) for its self ...
This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback